Experimental and clinical action of thromboxane A2 receptor antagonists.
Cinotti
G A
GA
Cattedra di Nefrologia Medica, University of Rome 'La Sapienza', Italy.
Pierucci
A
A
Menè
P
P
D016718:Arachidonic Acid; D001095:Arachidonic Acids / Q000378:metabolism; D001127:Arginine Vasopressin / Q000494:pharmacology; D002118:Calcium / Q000378:metabolism; D002478:Cells, Cultured; D005919:Glomerular Filtration Rate / Q000187:drug effects; D006801:Humans; D007098:Imino Acids / Q000627:therapeutic use*; D066298:In Vitro Techniques; D015759:Ionomycin / Q000494:pharmacology; D007668:Kidney / Q000378:metabolism; D008181:Lupus Nephritis / Q000188:drug therapy / Q000503:physiopathology; D008564:Membrane Potentials / Q000187:drug effects; D009130:Muscle, Smooth / Q000187:drug effects / Q000378:metabolism; D011189:Potassium Chloride / Q000494:pharmacology; D011982:Receptors, Prostaglandin / Q000037:antagonists & inhibitors*; D017482:Receptors, Thromboxane; D012079:Renal Circulation / Q000187:drug effects; D013050:Spectrometry, Fluorescence; D013928:Thromboxane A2
D001095:Arachidonic Acids; D007098:Imino Acids; D011982:Receptors, Prostaglandin; D017482:Receptors, Thromboxane; D001127:Arginine Vasopressin; C065280:BM 13677; D016718:Arachidonic Acid; D015759:Ionomycin; D013928:Thromboxane A2; D011189:Potassium Chloride; D002118:Calcium